Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions
- 23 February 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Hospital Infection
- Vol. 123, 92-99
- https://doi.org/10.1016/j.jhin.2022.02.010
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of KoreaJAMA Internal Medicine, 2020
- Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen typeDiagnostic Microbiology and Infectious Disease, 2020
- Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infectionEmergencias, 2020
- Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic PatientsJournal of Clinical Microbiology, 2020
- Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation StudyCell Reports Medicine, 2020
- Evaluation of the COVID19 ID NOW EUA assayJournal of Clinical Virology, 2020
- Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2Journal of Clinical Virology, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaborationBMJ Open, 2016